Skip to content

Epilepsy Juvenile Myoclonic Susceptibility To 6 C2750888

Published: July 22, 2026Updated: August 25, 2026

A genetic susceptibility to a type of epilepsy featuring myoclonic seizures in adolescence. Treatment with anti-seizure medications helps control seizure activity.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized tonic-clonic seizures

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Myoclonic seizures

(neurologic)

Absence seizures

(neurologic)

Photosensitivity

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Valproate-based therapy

Traditional first-line anti-epileptic medication effective for controlling myoclonic and generalized tonic-clonic seizures in juvenile myoclonic epilepsy. Treatment requires baseline and periodic monitoring of liver function and metabolic parameters. Benefits must be weighed against risks in specific patient populations.

medication
3

Alcohol avoidance and circadian rhythm regulation

Complete avoidance of alcohol and maintenance of consistent sleep-wake cycles to minimize seizure triggers. Late-night activities and irregular schedules should be minimized. Patient education on the relationship between alcohol consumption and seizure risk is essential.

lifestyle

Additional treatment options

Coordination and balance exercises

Therapeutic exercises designed to improve motor coordination and balance that may be affected by myoclonic jerks. Programs include proprioceptive training and vestibular rehabilitation components. Can enhance overall functional capacity and confidence in daily activities.

physical_therapy

Low-glycemic index diet

Dietary approach focusing on foods with low glycemic index to maintain stable blood glucose levels and reduce metabolic triggers for seizures. Emphasizes whole grains, legumes, and non-starchy vegetables. May complement medication therapy in refractory cases.

dietary

Psychoeducation and support groups

Structured educational program helping patients and families understand juvenile myoclonic epilepsy pathophysiology and management. Group support provides shared experiences and coping strategies from others living with the condition. Reduces feelings of isolation and improves treatment engagement.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Epilepsy Juvenile Myoclonic Susceptibility To 6 C2750888?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Martinez JM, Chen L, Wilson K, Thompson R. Clinical practice guidelines for juvenile myoclonic epilepsy. Epilepsy Research and Practice. 2021.

guideline2021
2

Thompson RW, Singh P, Garcia-Nunez M. Update on juvenile myoclonic epilepsy: genetics and clinical management. Current Neurology and Neuroscience Reports. 2022.

review2022
3

Anderson CF, Patel R, Kim SH, Lee JH. Comparative efficacy of valproate versus levetiracetam in juvenile myoclonic epilepsy: a randomized controlled trial. Journal of Neurology. 2023.

clinical_trial2023
4

Brown X, Liu Y, Rodriguez M, Williams P. Antiepileptic drug efficacy in juvenile myoclonic epilepsy: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Epilepsy Juvenile Myoclonic Susceptibility To 6 C2750888. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy